TREATMENT RESPONSE AND DISEASE BURDEN OF PATIENTS WITH RHEUMATOID ARTHRITIS IN TAIWAN

被引：0
|
作者：
Tang, C. H. [1 ]
Li, K. J. [2 ]
Liao, C. Y. [3 ]
Chuang, P. Y. [4 ]
Furnback, W. [5 ]
Wang, B. [5 ]
Kim, S. [6 ]
机构：
[1] Taipei Med Univ, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Astellas Pharma Taiwan Inc, Taipei, Taiwan
[4] Real Chem Inc, Whitestone, NY USA
[5] Real Chem Inc, New York, NY USA
[6] Astellas Pharma Singapore Pte Ltd, Singapore, Singapore
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD94
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 50 条
  • [41] Association of Pharmacogenetic Markers with Treatment Response in Patients with Rheumatoid Arthritis
    Schwarz, Ute I.
    Pope, Janet E.
    Keystone, Edward
    Haraoui, Boulos
    Thorne, Carter
    Choi, Yun-Hee
    Poulin-Costello, Melanie
    Bayan, Nabil
    Kim, Richard B.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S164 - S165
  • [42] Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment
    Brodszky, Valentin
    Balint, Peter
    Geher, Pal
    Hodinka, Laszlo
    Horvath, Gabor
    Koo, Eva
    Pentek, Marta
    Polgar, Anna
    Sesztak, Magdolna
    Szanto, Sandor
    Ujfalussy, Ilona
    Gulacsi, Laszlo
    RHEUMATOLOGY INTERNATIONAL, 2009, 30 (02) : 199 - 205
  • [43] Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment
    Valentin Brodszky
    Péter Bálint
    Pál Géher
    László Hodinka
    Gábor Horváth
    Éva Koó
    Márta Péntek
    Anna Polgár
    Magdolna Seszták
    Sándor Szántó
    Ilona Ujfalussy
    László Gulácsi
    Rheumatology International, 2009, 30 : 199 - 205
  • [44] A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis
    Michelsen, Brigitte
    Fiane, Ragnhild
    Diamantopoulos, Andreas P.
    Soldal, Dag Magnar
    Hansen, Inger Johanne W.
    Sokka, Tuulikki
    Kavanaugh, Arthur
    Haugeberg, Glenn
    PLOS ONE, 2015, 10 (04):
  • [45] Associations of Cost Sharing With Rheumatoid Arthritis Disease Burden
    Dowell, Sharon
    Swearingen, Christopher J.
    Pedra-Nobre, Manuela
    Wollaston, Dianne
    Najmey, Sawsan
    Elliott, Cynthia Lawrence
    Ford, Theresa Lawrence
    North, Heather
    Dore, Robin
    Dolatabadi, Soha
    Ramanujam, Thaila
    Kennedy, Stacy
    Ott, Stephanie
    Jileaeva, Ilona
    Richardson, Amina
    Wright, Grace
    Kerr, Gail S.
    ACR OPEN RHEUMATOLOGY, 2023, 5 (08) : 381 - 387
  • [46] The burden of rheumatoid arthritis
    Wolfe, F
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (14): : S852 - S859
  • [47] The burden of rheumatoid arthritis and access to treatment:: determinants of access
    Lundqvist, J.
    Kastaeng, F.
    Kobelt, G.
    Joensson, B.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S87 - S93
  • [48] The burden of rheumatoid arthritis and access to treatment: a medical overview
    J. Smolen
    D. Aletaha
    The European Journal of Health Economics, 2008, 8 : 39 - 47
  • [49] The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment
    Grega, Dominik
    Kolar, Jozef
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 40 : 13 - 18
  • [50] The burden of rheumatoid arthritis and access to treatment: determinants of access
    J. Lundqvist
    F. Kastäng
    G. Kobelt
    B. Jönsson
    The European Journal of Health Economics, 2008, 8 : 87 - 93
12345